Erythropoietin Drugs Market to Exhibit a Remarkable CAGR of 5.7% by 2028 | Allied Market Research

Erythropoietin Drugs Market Overview 2024 – 2028

As per the report published by Allied Market Research, the global Erythropoietin Drugs Market was pegged at $9.24 billion in 2020, and is estimated to reach $14.41 billion by 2028, growing at a CAGR of 5.7% from 2021 to 2028.

Growth of the market is driven by rise in number of treatment cycles for chemotherapy and increase in number cases including cancer, HIV, kidney diseases, and anemia.

Rise in prevalence of cancer, HIV, anemia, and kidney diseases, surge in level of awareness about the benefits of EPO therapeutics, and commercialization for erythropoietin biosimilars drive the growth of the global erythropoietin drugs market. However, longer duration of treatment, unaffordability of therapeutics, and adverse amount of side effects hinder the market growth. On the contrary, the commercialization of darbepoetin alfa biosimilar and achieving economies of scale across developed regions are expected to open lucrative opportunities for the market players in the future.

Request Sample Report at:

https://www.alliedmarketresearch.com/request-sample/59

Key Takeaways:

• The darbepoetin-alfa segment is estimated to register the highest CAGR of 7.0% during the forecast period.
• The segment is expected to manifest the highest CAGR of 6.5% during the forecast period.
• The market across Asia-Pacific is projected to register the highest CAGR of 7.8% from 2021 to 2028.

Economic Downturn Analysis: 

• Increased healthcare spending in developed and developing countries facilitates better access to EPO drugs.
• Government funding and insurance coverage for CKD and anemia treatments directly impact market growth.
• The high cost of EPO drugs can be a barrier, but the introduction of biosimilars helps reduce treatment costs and enhances market penetration.

Factors affecting the growth of the Erythropoietin Drugs Market:

1. Prevalence of Anemia and Chronic Kidney Disease (CKD):
   • EPO drugs are primarily used to treat anemia, especially in patients with chronic kidney disease (CKD). The increasing prevalence of these conditions significantly drives the demand for EPO drugs.
   • Rising incidences of cancer and the associated chemotherapy-induced anemia also contribute to market growth.
2. Advancements in Biotechnology:
   • Innovations in drug formulations and delivery mechanisms enhance the efficacy and convenience of EPO drugs, boosting their adoption.
   • Development of biosimilars (biologically similar products) has expanded treatment options and can lead to increased market competition and accessibility.
3. Awareness and Diagnosis:
   • Greater awareness and early diagnosis of anemia and CKD lead to timely treatment, thus increasing the usage of EPO drugs.

Connect to our Analyst: 

https://www.alliedmarketresearch.com/connect-to-analyst/59

Erythropoietin Drugs Market Segments:

By PRODUCTS

• Epoetin-alfa
• Epoetin-beta
• Darbepoetin-alfa
• Others

By APPLICATIONS

• Hematology
• Kidney Disorder
• Cancer
• Others

Geography:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Regional Analysis:

North America dominates the global erythropoietin drugs market, owing to presence of several approved and commercialized erythropoietin biosimilars. However, Asia-Pacific is characterized by presence of generic epoetin products. Asia-Pacific and LAMEA offer promising growth opportunities for erythropoietin manufacturers as these regions are less explored for erythropoietin drugs as compared to North America and Europe.

Leading Market Players: 

• Johnson & Johnson
• Amgen Inc.,
• Roche, Hospira Inc.
• Biocon
• LG Life Sciences Ltd.
• Teva Pharmaceutical Industries Ltd.
• Intas Pharmaceuticals
• Ranbaxy Laboratories Ltd.,
• Celltrion, Inc.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Request Customization: 

https://www.alliedmarketresearch.com/request-for-customization/59

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Data
David Correa

1209 Orange Street, Corporation Trust Center, Wilmington, New Castle, Delaware 19801 USA.

Toll Free: +1-800-792-5285| Int’l: +1-503-894-6022

UK: +44-845-528-1300| Hong Kong: +852-301-84916

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

Trending Reports in Healthcare Industry (Book Now with Discount):

Medical Device Packaging Market Research Report 2024 To 2032 

Acupuncture Needles Market Research Report 2024 To 2032 

Veterinary Medicine Market Research Report 2024 To 2032 

Implantable Insulin Pump Market Research Report 2024 To 2032